A sequential two meal challenge reveals abnormalities in postprandial TAG but not glucose in men with increasing numbers of metabolic syndrome components

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 237-243

  Jackson, Kim G ^a   Walden, Charlotte M ^b   Murray, Peter ^b   Smith, Adrian M ^b   Lovegrove, Julie A ^a   Minihane, Anne M ^a,c   Williams, Christine M ^a  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNILEVER RESEARCH   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Fasting lipids; Non esterified fatty acids; Postprandial lipaemia; Sequential test meal protocol

Indexed keywords

FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE; BLOOD SAMPLING; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MEAL; METABOLIC SYNDROME X; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; ENGLAND; FATTY ACIDS, NONESTERIFIED; HUMANS; HYPERLIPIDEMIAS; INSULIN; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POSTPRANDIAL PERIOD; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TRIGLYCERIDES;

EID: 84155164035     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.09.047     Document Type: Article

References (37)

1. Bansal S., Buring J.E., Rifai N., Mora S., Sacks F.M., Ridker P.M. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. The Journal of the American Medical Association 2007, 298:309-316.
2. Nordestgaard B.G., Benn M., Schnohr P., Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. The Journal of the American Medical Association 2007, 298:299-308.
3. Lindman A.S., Veierod M.B., Tverdal A., Pedersen J.I., Selmer R. Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study. European Journal of Epidemiology 2010, 25:789-798.
4. van Wijk J.P.H., Halkes C.J.M., Erkelens D.W., Cabezas M.C. Fasting and daylong triglycerides in obesity with and without type 2 diabetes. Metabolism Clinical and Experimental 2003, 52:1043-1049.
5. Gami A.S., Witt B.J., Howard D.E., et al. Metabolic syndrome and risk of incident cardiovascular events and death - a systematic review and meta-analysis of longitudinal studies. Journal of the American College of Cardiology 2007, 490:403-414.
6. Lorenzo C., Williams K., Hunt K.J., Haffner S.M. The national cholesterol education program-adult treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007, 30:8-13.
7. Alberti K., Eckel R.H., Grundy S.M., et al. Harmonizing the metabolic syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
8. Sundstrom J., Vallhagen E., Riserus U., et al. Risk associated with the metabolic syndrome versus the sum of its individual components. Diabetes Care 2006, 29:1673-1674.
9. Guize L., Thomas F., Pannier B., Bean K., Jego B., Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care 2007, 30:2381-2387.
10. Franco O.H., Massaro J.M., Civil J., Cobain M.R., O'Malley B., D'Agostino R.B. Trajectories of entering the metabolic syndrome the Framingham heart study. Circulation 2009, 120:1943-1950.
11. Haring R., Wallaschofski H., Nauck M., et al. Total and cardiovascular disease mortality predicted by metabolic syndrome is inferior relative to its components. Experimental and Clinical Endocrinology & Diabetes 2010, 118:685-691.
12. Simons L.A., Simons J., Friedlander Y., McCallum J. Is Prediction of cardiovascular disease and all-cause mortality genuinely driven by the metabolic syndrome, and independently from its component variables? The dubbo study. Heart Lung and Circulation 2011, 20:214-219.
13. Sone H., Tanaka S., Iimuro S., et al. Components of metabolic syndrome and their combinations as predictors of cardiovascular disease in Japanese patients with type 2 diabetes. Implications for improved definition. Analysis from Japan Diabetes Complications Study (JDCS). Journal of Atherosclerosis and Thrombosis 2009, 16:380-387.
14. Thomas G.N., Phillips A.C., Carroll D., Gale C.R., Batty G.D. The metabolic syndrome adds utility to the prediction of mortality over its components: the Vietnam experience study. Atherosclerosis 2010, 210:256-261.
15. Salpea K.D., Tsarpalis K.K., Kolovou G.D., et al. Metabolic syndrome and gender differences in postprandial lipaemia. European Heart Journal 2006, 27:940.
16. Ntyintyane L.M., Panz V.R., Raal F.J., Gill G.V. Postprandial lipaemia, metabolic syndrome and LDL particle size in urbanised South African blacks with and without coronary artery disease. QJM An International Journal of Medicine 2008, 101:111-119.
17. Jackson K.G., Clarke D.T., Murray P., et al. Introduction to the DISRUPT postprandial database: subjects, studies and methodologies. Genes Nutrition 2009, 5:39-48.
18. 2+ high-density-lipoprotein cholesterol precipitation method for use with previously frozen plasma. Clinical Chemistry 1994, 40:233-239.
19. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment - insulin resistance and beta-cell function from fasting plasma-glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
20. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome - an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112:2735-2752.
21. Sattar N., Gaw A., Scherbakova O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003, 108:414-419.
22. Ridker P.M., Buring J.E., Cook N.R., Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation 2003, 107:391-397.
23. Espinola-Klein C., Rupprecht H.J., Bickel C., et al. Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis. American Journal of Cardiology 2007, 99:1623-1628.
24. Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: time for a critical appraisal - joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28:2289-2304.
25. Okosun I.S., Tedders S.H., Choi S., Dever G.E.A. Abdominal adiposity values associated with established body mass indexes in white, black and hispanic Americans. A study from the Third National Health and Nutrition Examination survey. International Journal of Obesity 2000, 24:1279-1285.
26. Janssen I. Influence of age on the relation between waist circumference and cardiometabolic risk markers. Nutrition, Metabolism and Cardiovascular Diseases 2009, 19:163-169.
27. Zhu S.K., Heshka S., Wang Z.M., et al. Combination of BMI and waist circumference for identifying cardiovascular risk factors in whites. Obesity Research 2004, 12:633-645.
28. Gylling H., Hallikainen M., Pihlajamaki J., et al. Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: lessons from the METSIM Study. Journal of Lipid Research 2010, 51:2422-2427.
29. Meshkani R., Adeli K. Hepatic insulin resistance, metabolic syndrome and cardiovascular disease. Clinical Biochemistry 2009, 42:1331-1346.
30. Bickerton A.S.T., Roberts R., Fielding B.A., et al. Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia 2008, 51:1466-1474.
31. Robertson A.D., Jackson K.G., Fielding B.A., Williams C.M., Frayn K.N. Acute effects of meal fatty acid composition on insulin sensitivity in healthy post-menopausal women. British Journal of Nutrition 2002, 88:635-640.
32. Fielding B.A., Callow J., Owen R.M., Samra J.S., Matthews D.R., Frayn K.N. Postprandial lipemia: the origin of an early peak studied by specific dietary fatty acid intake during sequential meals. American Journal of Clinical Nutrition 1996, 63:36-41.
33. Burdge G.C., Jones A.E., Frye S.M., Goodson L., Wootton S.A. Effect of meal sequence on postprandial lipid, glucose and insulin responses in young men. European Journal of Clinical Nutrition 2003, 57:1536-1544.
34. Pedersen A., Marckmann P., Sandstrom B. Postprandial lipoprotein, glucose and insulin responses after two consecutive meals containing rapeseed oil, sunflower oil or palm oil with or without glucose at the first meal. British Journal of Nutrition 1999, 82:97-104.
35. Minihane A.M., Khan S., Leigh-Firbank E.C., et al. ApoE polymorphism and fish oil supplementation in subjects with an antherogenic lipoprotein phenotype. Arteriosclerosis Thrombosis and Vascular Biology 2000, 20:1990-1997.
36. Silva K.D.R., Kelly C.N.M., Jones A.E., et al. Chylomicron particle size and number, factor VII activation and dietary monounsaturated fatty acids. Atherosclerosis 2003, 166:73-84.
37. van Oostrom A., Alipour A., Sijmonsma T.P., et al. Comparison of different methods to investigate postprandial lipaemia. Netherlands Journal of Medicine 2009, 67:13-20.